Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

02 mars 2021 09h00 HE | Source: National Lipid Association

National Lipid Association and Paradigm Medical Communications, LLC Announce Collaborative Partnership in Lipids Education

JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical...
17 mars 2016 16h01 HE | Source: CymaBay Therapeutics, Inc.

CymaBay Therapeutics Announces Positive Results from its Pilot Phase 2 Clinical Study of MBX-8025 in Patients with Homozygous Familial Hypercholesterolemia

NEWARK, Calif., March 17, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY) today announced top line results from its pilot Phase 2 clinical study of MBX-8025 in patients with...
24 sept. 2014 09h00 HE | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day

CAMBRIDGE, Mass., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to...